The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
The worldwide outbreak of SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
as a novel human coronavirus, was the worrying news at the beginning of 2020. Since its …
as a novel human coronavirus, was the worrying news at the beginning of 2020. Since its …
COVID-19: Targeting proteases in viral invasion and host immune response
S Seth, J Batra, S Srinivasan - Frontiers in Molecular Biosciences, 2020 - frontiersin.org
An acute respiratory disorder (COVID-19) that accelerated across the globe has been found
to be caused by a novel strain of coronaviruses (SARS-CoV-2). The absence of a specific …
to be caused by a novel strain of coronaviruses (SARS-CoV-2). The absence of a specific …
COVID‐19: Clinical status of vaccine development to date
S Kumar, M Basu, P Ghosh, A Ansari… - British Journal of …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)‐induced COVID‐19 is a
complicated disease. Clinicians are continuously facing difficulties to treat infected patients …
complicated disease. Clinicians are continuously facing difficulties to treat infected patients …
Middle East respiratory syndrome vaccine candidates: cautious optimism
C Schindewolf, VD Menachery - Viruses, 2019 - mdpi.com
Efforts towards developing a vaccine for Middle East respiratory syndrome coronavirus
(MERS-CoV) have yielded promising results. Utilizing a variety of platforms, several vaccine …
(MERS-CoV) have yielded promising results. Utilizing a variety of platforms, several vaccine …
Evaluation of neutralizing antibodies against highly pathogenic coronaviruses: a detailed protocol for a rapid evaluation of neutralizing antibodies using vesicular …
SA Almahboub, A Algaissi, MA Alfaleh… - Frontiers in …, 2020 - frontiersin.org
Emerging highly pathogenic human coronaviruses (CoVs) represent a serious ongoing
threat to the public health worldwide. The spike (S) proteins of CoVs are surface …
threat to the public health worldwide. The spike (S) proteins of CoVs are surface …
Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection
Middle East respiratory syndrome coronavirus (MERS-CoV) continues to cause outbreaks in
humans as a result of spillover events from dromedaries. In contrast to humans, MERS-CoV …
humans as a result of spillover events from dromedaries. In contrast to humans, MERS-CoV …
[HTML][HTML] Advances in mRNA and other vaccines against MERS-CoV
Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic human
coronavirus (CoV). Belonging to the same beta-CoV genus as severe acute respiratory …
coronavirus (CoV). Belonging to the same beta-CoV genus as severe acute respiratory …
[HTML][HTML] SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies
L Huang, Y Rong, Q Pan, K Yi, X Tang, Q Zhang… - Asian journal of …, 2021 - Elsevier
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
Unraveling the epidemiology, geographical distribution, and genomic evolution of potentially lethal coronaviruses (SARS, MERS, and SARS CoV-2)
SARS CoV appeared in 2003 in China, transmitted from bats to humans via eating infected
animals. It affected 8,096 humans with a death rate of 11% affecting 21 countries. The …
animals. It affected 8,096 humans with a death rate of 11% affecting 21 countries. The …
Harnessing memory NK cell to protect against COVID-19
S Soleimanian, R Yaghobi - Frontiers in pharmacology, 2020 - frontiersin.org
The worldwide struggle against the coronavirus disease 2019 (COVID-19) as a public health
crisis continues to sweep across the globe. Up to now, effective antiviral treatment against …
crisis continues to sweep across the globe. Up to now, effective antiviral treatment against …